Screening for depression in a hepatitis C population: The reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D)

Journal of Advanced Nursing

Volumn 40, Issue 3, 2002, Pages 361-369

  Clark, Cinda H ^a   Mahoney, Jane S ^b   Clark, David J ^a   Eriksen, Lillian R ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON   (United States)

Author keywords

Antiviral therapy; Center for Epidemiological Studies Depression Scale; Depression; Depression screening; Hepatitis C; Interferon; Psychometric testing; Reliability; Ribavirin; Validity

Indexed keywords

ADULT; ARTICLE; DEPRESSION; FACTORIAL ANALYSIS; FEMALE; HEPATITIS C; HUMAN; LONGITUDINAL STUDY; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; SENSITIVITY AND SPECIFICITY; STANDARD; TIME; VALIDATION STUDY;

ADULT; DEPRESSIVE DISORDER; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEPATITIS C; HUMANS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0036836096     PISSN: 03092402     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2648.2002.02378.x     Document Type: Article

References (41)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric-Publishing, Washington, DC.
2. Beck A.T. (1971) Cognition, affect, and psychopathology. Archives of General Psychiatry 24, 495-500.
3. Beck A.T., Ward C.H. & Mendelson M. (1961) An inventory for measuring depression. Archives of General Psychiatry 4, 861-871.
4. Beekman A.T., Deeg D.J., Van Limbeck J., Braam A.W., De Vries M.Z. & van Tilburg W. (1997) Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychology and Medicine 27, 231-235.
5. Berkman L.F., Berkman C.S. & Kasl S. (1986) Depressive symptoms in relation to physical health and functioning in the elderly. American Journal of Epidemology 124, 372-388.
6. Blazer D., Burchett B., Service C. & George L. (1991) The association of age and depression among the elderly: an epidemiologic exploration. Journal of Gerontology 46, 210-215.
7. Bonaccoro S., Puzella A., Marino V., Pasquini M., Biondi M., Artini M., Almerighi C., Levrero M., Egyed B., Bosmans E., Meltzer H.Y. & Maes M. (2001) Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Research 105, 45-55.
8. Callahan C.M. & Wolinsky F.D. (1994) The effect of gender and race on the measurement properties of the CES-D in older adults. Medical Care 32, 341-356.
9. Clark C., Mahoney J., Eriksen L. & Ghalib R. (1999) Validation of the Center for Epidemiologic Studies Depression Scale (CES-D) in hepatitis C patients. Hepatology 30, 816A.
10. Costa M.A. (1999) Hepatitis C. Current Treatment Options in Gastroenterology 2, 481-490.
11. Dahlstrom W.G. & Welsh G.S. (1960) An MMPI Handbook. University of Minnesota Press, Minneapolis, MN.
12. Davidson H., Feldman P.H. & Crawford S. (1994) Measuring depressive symptoms in the frail elderly. Journal of Gerontology 49, P159-P164.
13. Dusheiko G. (1997) Side effects of alpha interferon in chronic hepatitis C. Hepatology 26(3 Suppl. 1), 112S-121S.
14. Dwight M., Kowdley K.V., Russo J.E., Ciechanowski P.S., Larson A.M. & Katon W.J. (2000) Depression, fatigue, and functional disability in patients with chronic hepatitis C. Journal of Psychosomatic Research 49, 311-317.
15. Fontana R.J. (2000) Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C. Digestive Diseases 18, 107-116.
16. Gorsuch R.L. (1983) Factor Analysis, 2nd edn. Lawrence Erlbaum Associates Publishers, Hillsdale, NJ.
17. Hakozaki Y., Shirahama T., Katou M., Nakagawa K., Oba K. & Mitamura K. (1995) A controlled study to determine the optimal dose regimen of interferon-alpha 2b in chronic hepatitis C. American journal of Gastroenterology 90, 1246-1249.
18. Hann D., Winter K. & Jacobsen P. (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression scale (CES-D). Journal of Psychosomatic Research 46, 437-443.
19. Heeringa M., Honkoop P., de Man R.A., Feenstr J. & Smits C.M. (1998) Major psychiatric side effects of interferon alpha-2b. Ned Tijdschr Geneenskd 142, 1618-1621.
20. Janssen H.L., Brouwer J.T., van der Mast R.C. & Schalm S.W. (1994) Suicide associated with alfa-interferon therapy for chronic viral hepatitis. Journal of Hepatolology 21, 241-243.
21. Lewinsohn P.M., Seeley J.R., Roberts R.E. & Allen N.B. (1997) Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychology and Aging 12, 277-287.
22. Lyon D.E. & Munro C. (2001) Disease severity and symptoms of depression in black Americans infected with HIV. Applied Nursing Research 14, 3-10.
23. Maddrey W.C. (1999) Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C -relapse and treatment-naive patients. Seminars in Liver Disease 19(Suppl. 1), 67-75.
24. Miyaoka H., Otsubo T., Kamijima K., Ishii M., Onuki M. & Mitamura K. (1999) Depression from interferon therapy in patients with hepatitis C. American Journal of Psychiatry 156, 1120.
25. National Institute of Health (NIH) (1997) Consensus statement: Management of Hepatitis C. Continuing Medical Education 15, 1-41.
26. Nunnally J.C. & Bernstein I.H. (1994) Psychometric Theory, 3rd edn. McGraw-Hill Inc, New York.
27. Parik R.M., Eden D.T., Price T.R. & Robinson R.G. (1988) The sensitivity and specificity of the Center for Epidemiologic Studies Depression Scale in screening for post-stroke depression. International Journal of Psychiatry and Medicine 18, 169-181.
28. Radloff L.S. (1977) The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1, 385-401.
29. Rifflet H., Vuillemin E., Oberti F., Duverger P., Laine P., Garre J.B. & Cales P. (1998) Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha. Gastroenterologic Clinical Biology 22, 353-357.
30. Rush A.J., Golden W.E., Hall G.W., Herrera M., Houston A., Kathol R.G., Katon W., Matchett C.L., Petty F., Schulberg H.C., Smith G.R. & Stuart G.W. (1993) Depression in Primary Care: Vol. 1. Detection and Prevention (AHCPR Publication no. PHS 93-0550). Department of Human Services, Rockville, MD.
31. Savetsky J.B., Sullivan L.M., Clark J., Stein M.D. & Samet J.H. (2001) Evolution of depressive symptoms in human immunodeficiency virus-infected patients entering primary care. Journal of Nervous and Mental Disorders 189, 76-83.
32. Schaeffer J.J., Gill K.M., Burchinal M., Kramer K.D., Nash K., Orringer E. & Strawhorn D. (1999) Depression, disease, severity, and sickle cell disease. Journal of Behavioral Medicine 22, 115-126.
33. Somervell P.D., Beals J., Kinzie J.D., Boehnien J., Leung P. & Manson S.M. (1993) Criterion validity of the Center for Epidemiologic Studies Depression Scale in a population sample from an American Indian village. Psychiatric Research 47, 255-266.
34. Thomas J.L., Jones G.N., Scarinci I.C., Mehan D.J. & Brantley P.J. (2001) International Journal of Psychiatry and Medicine 31, 25-40.
35. Verdier-Taillefer M., Gourlet V., Fuhrer R. & Alperovitch A. (2001) Psychometric properties of the Center for Epidemiologic Studies-Depression scale in multiple sclerosis. Nueroepidemiology 20, 262-267.
36. Wassertheil-Smoller S., Applegate W.B., Berge K., Chang C.J., Davis B.R., Grimm R., Kostis J., Pressel S. & Schron E. (1996) Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group. Archives of Internal Medicine 156, 553-561.
37. Weissman M.M., Sholomskas D., Pottenger M., Prusoff B.A. & Locke B.Z. (1977) Assessing depressive symptoms in five psychiatric populations: a validation study. American Journal of Epidemiology 106, 203-214.
38. Wilson-Schaeffer J.J., Gil K.M., Burchinal M., Kramer K.D., Nash K.B., Orringer E. & Strayhorn D. (1999) Depression, disease severity, and sickle cell disease. Journal of Behavioral Medicine 22, 115-126.
39. Wright I.A. (2000) Monitoring depression in patients undergoing alpha-interferon and ribavirin therapy for hepatitis C. Gastroenterology Nursing 23, 275-280.
40. Zich J.M., Attkisson C.C. & Greenfield T.K. (1990) Screening for depression in primary care clinics: the CES-D and the BDI. International Journal of Psychiatry and Medicine 20, 259-277.
41. Zung W.W. (1965) A self-rating depression scale. Archives of General Psychiatry 12, 63-70.